{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:03:29Z","timestamp":1788318209989,"version":"build-2803163510"},"reference-count":76,"publisher":"Impact Journals, LLC","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,22]]},"DOI":"10.18632\/oncotarget.6180","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T23:01:52Z","timestamp":1445641312000},"page":"43508-43528","source":"Crossref","is-referenced-by-count":31,"title":["Anti-leukemic effects of the V-ATPase inhibitor Archazolid A"],"prefix":"10.18632","volume":"6","author":[{"given":"Siwei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina S.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binje","family":"Vick","sequence":"additional","affiliation":[{"name":"Department of Gene Vectors, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Munich, Germany"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Grunert","sequence":"additional","affiliation":[{"name":"Department of Gene Vectors, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmela","family":"Jeremias","sequence":"additional","affiliation":[{"name":"Department of Gene Vectors, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Munich, Germany"},{"name":"Department of Oncology\/Hematology, Dr. von Haunersches Kinderspital, Munich, Germany"},{"name":"German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Menche","sequence":"additional","affiliation":[{"name":"Kekul\u00e9-Institut f\u00fcr Organische Chemie und Biochemie der Universit\u00e4t Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbr\u00fccken, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika M.","family":"Vollmar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Liebl","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Ferrando","year":"2012","journal-title":"J Clin Invest"},{"key":"2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2011.06.005","article-title":"Notch in T-ALL: new players in a complex disease","volume":"32","author":"Radtke","year":"2011","journal-title":"Trends Immunol"},{"key":"3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/1471-2407-11-502","article-title":"Current views on the role of Notch signaling and the pathogenesis of human leukemia","volume":"11","author":"Nicot","year":"2011","journal-title":"BMC Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.18632\/oncotarget.4116","article-title":"Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL","volume":"6","author":"Rosati","year":"2015","journal-title":"Oncotarget"},{"key":"5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","article-title":"Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells","volume":"113","author":"Marconi","year":"2009","journal-title":"Blood"},{"key":"6","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/ijc.27863","article-title":"gamma-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation","volume":"132","author":"Marconi","year":"2013","journal-title":"Int J Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00277-015-2413-0","article-title":"HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia","volume":"94","author":"Zhang","year":"2015","journal-title":"Annals of hematology"},{"key":"8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20121527","article-title":"Notch activation inhibits AML growth and survival: a potential therapeutic approach","volume":"210","author":"Zweidler-McKay","year":"2013","journal-title":"J Exp Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/leu.2014.281","article-title":"Hes1 suppresses acute myeloid leukemia development through FLT3 repression","volume":"29","author":"Yagita","year":"2015","journal-title":"Leukemia"},{"key":"10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1083\/jcb.200708127","article-title":"Endosomal entry regulates Notch receptor activation in Drosophila melanogaster","volume":"180","author":"Bilder","year":"2008","journal-title":"J Cell Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1242\/dev.045484","article-title":"The vacuolar ATPase is required for physiological as well as pathological activation of the Notch receptor","volume":"137","author":"Bilder","year":"2010","journal-title":"Development"},{"key":"12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrm729","article-title":"The vacuolar (H+)-ATPases\u2014nature's most versatile proton pumps","volume":"3","author":"Forgac","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrm2272","article-title":"Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology","volume":"8","author":"Forgac","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1074\/jbc.M114.611210","article-title":"Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells","volume":"290","author":"Forgac","year":"2015","journal-title":"J Biol Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1074\/jbc.M112.412007","article-title":"Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition","volume":"288","author":"Vollmar","year":"2013","journal-title":"J Biol Chem"},{"key":"16","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1158\/0008-5472.CAN-12-1772","article-title":"The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1","volume":"72","author":"Vollmar","year":"2012","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1535-7163.MCT-13-0484","article-title":"V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells","volume":"13","author":"Vollmar","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.28562","article-title":"V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation","volume":"134","author":"Wagner","year":"2014","journal-title":"Int J Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/labinvest.2011.8","article-title":"The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer","volume":"91","author":"Gorelick","year":"2011","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"key":"20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1541-7786.MCR-10-0449","article-title":"The a3 isoform vacuolar type H(+)-ATPase promotes distant metastasis in the mouse B16 melanoma cells","volume":"9","author":"Yoneda","year":"2011","journal-title":"Mol Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ijc.27811","article-title":"Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion","volume":"132","author":"Parra","year":"2013","journal-title":"Int J Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bbadis.2013.04.003","article-title":"V-ATPase is a candidate therapeutic target for Ewing sarcoma","volume":"1832","author":"Baldini","year":"2013","journal-title":"Biochimica et biophysica acta"},{"key":"23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yexcr.2013.10.011","article-title":"V-ATPase as an effective therapeutic target for sarcomas","volume":"320","author":"Baldini","year":"2014","journal-title":"Exp Cell Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.18632\/oncotarget.4239","article-title":"The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma","volume":"6","author":"Vaira","year":"2015","journal-title":"Oncotarget"},{"key":"25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.taap.2014.08.033","article-title":"Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B","volume":"281","author":"Efferth","year":"2014","journal-title":"Toxicology and applied pharmacology"},{"issue":"Pt 3","key":"26","first-page":"341","article-title":"Inhibitors of V-ATPases: old and new players","volume":"212","author":"Wieczorek","year":"2009","journal-title":"J Exp Biol"},{"key":"27","doi-asserted-by":"crossref","first-page":"38304","DOI":"10.1074\/jbc.M110.137539","article-title":"Archazolid A binds to the equatorial region of the c-ring of the vacuolar H+-ATPase","volume":"285","author":"Huss","year":"2010","journal-title":"J Biol Chem"},{"key":"28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2091-6-13","article-title":"Archazolid and apicularen: novel specific V-ATPase inhibitors","volume":"6","author":"Wieczorek","year":"2005","journal-title":"BMC biochemistry"},{"key":"29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejcb.2011.04.009","article-title":"Vacuolar H(+)-ATPases: intra- and intermolecular interactions","volume":"90","author":"Wieczorek","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7164\/antibiotics.56.520","article-title":"Archazolids, new cytotoxic macrolactones from Archangium gephyra (Myxobacteria). Production, isolation, physico-chemical and biological properties","volume":"56","author":"Reichenbach","year":"2003","journal-title":"The Journal of antibiotics"},{"key":"31","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1021\/ja071461o","article-title":"Total synthesis of archazolid A","volume":"129","author":"Rudolph","year":"2007","journal-title":"Journal of the American Chemical Society"},{"key":"32","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1021\/ja0733033","article-title":"Total synthesis of (\u2212)-archazolid B","volume":"129","author":"Trauner","year":"2007","journal-title":"Journal of the American Chemical Society"},{"key":"33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10456-013-9408-z","article-title":"Regulation of endothelial signaling and migration by v-ATPase","volume":"17","author":"Zahler","year":"2014","journal-title":"Angiogenesis"},{"key":"34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molonc.2013.08.011","article-title":"V-ATPase inhibition overcomes trastuzumab resistance in breast cancer","volume":"8","author":"Vollmar","year":"2014","journal-title":"Mol Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molonc.2013.11.002","article-title":"Pharmacologic inhibition of vacuolar H+ ATPase reduces physiologic and oncogenic Notch signaling","volume":"8","author":"Vaccari","year":"2014","journal-title":"Mol Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ctrv.2009.08.003","article-title":"V-ATPase inhibitors and implication in cancer treatment","volume":"35","author":"Garcia-Garcia","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.devcel.2009.07.001","article-title":"The vacuolar proton pump, V-ATPase, is required for notch signaling and endosomal trafficking in Drosophila","volume":"17","author":"Schupbach","year":"2009","journal-title":"Dev Cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/ncomms2624","article-title":"Impaired endolysosomal function disrupts Notch signalling in optic nerve astrocytes","volume":"4","author":"Sinha","year":"2013","journal-title":"Nat Commun"},{"key":"39","doi-asserted-by":"crossref","first-page":"e52798","DOI":"10.1371\/journal.pone.0052798","article-title":"imaging enables high resolution preclinical trials on patients\u2018 leukemia cells growing in mice","volume":"7","author":"Jeremias","year":"2012","journal-title":"PLoS One"},{"key":"40","doi-asserted-by":"crossref","first-page":"e0120925","DOI":"10.1371\/journal.pone.0120925","article-title":"An advanced preclinical mouse model for acute myeloid leukemia using patients\u2018 cells of various genetic subgroups andbioluminescence imaging","volume":"10","author":"Spiekermann","year":"2015","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood-2011-04-351239","article-title":"Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia","volume":"118","author":"Crispino","year":"2011","journal-title":"Blood"},{"issue":"10","key":"43","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/leu.2014.96","article-title":"Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein","volume":"28","author":"Bosch","year":"2014","journal-title":"Leukemia"},{"key":"44","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1158\/0008-5472.CAN-14-2097","article-title":"Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer","volume":"75","author":"Vollmar","year":"2015","journal-title":"Cancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/jcp.2003.015032","article-title":"The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis","volume":"57","author":"van der Wall","year":"2004","journal-title":"Journal of clinical pathology"},{"key":"46","first-page":"853","article-title":"Dynamic balancing of the dual nature of HIF-1alpha for cell survival","volume":"3","author":"Huang","year":"2004","journal-title":"Cell Cycle"},{"key":"47","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1038\/cddis.2011.48","article-title":"Reciprocal influence of the p53 and the hypoxic pathways","volume":"2","author":"Michiels","year":"2011","journal-title":"Cell death & disease"},{"key":"48","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","article-title":"Control of apoptosis by p53","volume":"22","author":"Lowe","year":"2003","journal-title":"Oncogene"},{"key":"49","first-page":"45","article-title":"Vacuolar H+-ATPase is down-regulated by the angiogenesis-inhibitory pigment epithelium-derived factor in metastatic prostate cancer cells","volume":"60","author":"Martinez-Zaguilan","year":"2014","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"50","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1074\/jbc.M901201200","article-title":"Function of a subunit isoforms of the V-ATPase in pH homeostasis andinvasion of MDA-MB231 human breast cancer cells","volume":"284","author":"Forgac","year":"2009","journal-title":"J Biol Chem"},{"key":"51","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jcb.24978","article-title":"CERS2 Suppresses Tumor Cell Invasion and Is Associated with Decreased V-ATPase and MMP-2\/MMP-9 activities in Breast Cancer","volume":"116","author":"Cheng","year":"2015","journal-title":"J Cell Biochem"},{"key":"52","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.18632\/oncotarget.1699","article-title":"Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis","volume":"5","author":"Webster","year":"2014","journal-title":"Oncotarget"},{"key":"53","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bcp.2014.07.028","article-title":"Targeting V-ATPase in primary human monocytes by archazolid potently represses the classical secretion of cytokines due to accumulation at the endoplasmic reticulum","volume":"91","author":"Werz","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"54","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"Fais","year":"2007","journal-title":"Cancer Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1172\/JCI64180","article-title":"Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors","volume":"123","author":"Spagnuolo","year":"2013","journal-title":"J Clin Invest"},{"key":"56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000305344","article-title":"Adhesion-induced drug resistance in leukemia stem cells","volume":"86","author":"Asano","year":"2010","journal-title":"Pharmacology"},{"key":"57","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors","volume":"204","author":"Look","year":"2007","journal-title":"J Exp Med"},{"key":"58","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","article-title":"Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia","volume":"108","author":"Kulozik","year":"2006","journal-title":"Blood"},{"key":"59","first-page":"1212","article-title":"The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols","volume":"91","author":"Pieters","year":"2006","journal-title":"Haematologica"},{"key":"60","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol","volume":"27","author":"Linch","year":"2009","journal-title":"J Clin Oncol"},{"key":"61","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V97.9.2784","article-title":"Cytokine-regulated expression of survivin in myeloid leukemia","volume":"97","author":"Andreeff","year":"2001","journal-title":"Blood"},{"key":"62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1182\/blood-2012-02-409888","article-title":"Survivin is highly expressed in CD34(+)38(\u2212) leukemic stem\/progenitor cells and predicts poor clinical outcomes in AML","volume":"120","author":"Kornblau","year":"2012","journal-title":"Blood"},{"key":"63","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/leu.2014.183","article-title":"Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1","volume":"29","author":"Pelus","year":"2015","journal-title":"Leukemia"},{"key":"64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/156652411797536723","article-title":"Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies","volume":"11","author":"Robak","year":"2011","journal-title":"Curr Mol Med"},{"key":"65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bjh.12663","article-title":"Differential expression of BIRC family genes in chronic myeloid leukaemia\u2014BIRC3 and BIRC8 as potential new candidates to identify disease progression","volume":"164","author":"Stoklosa","year":"2014","journal-title":"Br J Haematol"},{"key":"66","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pbc.24822","article-title":"BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group","volume":"61","author":"Meshinchi","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2012.03.005","article-title":"Targeting survivin in cancer","volume":"332","author":"Altieri","year":"2013","journal-title":"Cancer Lett"},{"key":"68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPH.0b013e3182a8f58f","article-title":"A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium","volume":"36","author":"Carroll","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"69","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2012-05-427773","article-title":"Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia","volume":"121","author":"Waldmann","year":"2013","journal-title":"Blood"},{"key":"70","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1158\/1078-0432.CCR-07-0686","article-title":"The universal character of the tumor-associated antigen survivin","volume":"13","author":"Straten","year":"2007","journal-title":"Clin Cancer Res"},{"key":"71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc968","article-title":"Validating survivin as a cancer therapeutic target","volume":"3","author":"Altieri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"72","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/leu.2014.325","article-title":"Myelodysplasia is in the niche-novel concepts and emerging therapies","volume":"29","author":"Platzbecker","year":"2015","journal-title":"Leukemia"},{"key":"73","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-013-1703-7","article-title":"Efficacy and safety of deferasirox in myelodysplastic syndromes","volume":"92","author":"Alimena","year":"2013","journal-title":"Ann Hematol"},{"key":"74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Riccardi","year":"1991","journal-title":"J Immunol Methods"},{"key":"75","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1158\/1535-7163.MCT-08-0299","article-title":"Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells","volume":"7","author":"Tuosto","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"76","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/ncomms8274","article-title":"Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2","volume":"6","author":"Zahler","year":"2015","journal-title":"Nat Commun"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T04:54:33Z","timestamp":1599713673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":76,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2015,12,22]]}},"alternative-id":["6180","26496038"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6180","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}